Articles of the Month
Videos
Articles
Neonatal skin dysbiosis to infantile atopic dermatitis: Mitigating effects of skin care
Aoyama, R., Nakagawa, S., Ichikawa, Y., et al. Allergy. First published: 09 March 2024
Legends of allergy and immunology: Kenji Izuhara
Nunomura, S., Sugita, K. and Arima, K. Allergy. First published: 08 March 2024
Generation of a virus-like particles based vaccine against IgE
Gharailoo Z, Plattner K, Augusto G, et al. Allergy. First published: 07 March 2024
Type 1/17 CD103+CD4+ nasal-resident memory T cells in non-eosinophilic chronic rhinosinusitis with nasal polyps
Rha, M.-S., Kim, G., Lee, S., et al. Allergy. First published: 06 March 2024
Efficacy and safety of topical Streptococcus postbiotic emollient in adolescents and adults with mild-to-moderate atopic dermatitis: A randomized, double-blind, vehicle-controlled trial
Kim, M.S., Kim, H.J., Kang, S.M., et al. Allergy. First published: 04 March 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination
Valk AM, Keijser JBD, van Dam KPJ, et al. Allergy. First published: 04 March 2024
Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases
Berni Canani R, Caminati M, Carucci L, Eguiluz-Gracia I. Allergy. First published: 04 March 2024
Climate crisis paralysis: Accelerating global action for health resilience in a changing world
Orasche, J., Nadeau, K.C., Schuster, A., Rockström, J., Akdis, C.A. and Traidl-Hoffmann, C. Allergy. First published: 04 March 2024
Core Outcome Set for IgE-mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘COMFA’
Demidova A, Drewitz KP, Kimkool P, et al. Allergy. First published: 03 March 2024
House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control—A RWE study
Jutel M, Klimek L, Richter H, Brüggenjürgen B, Vogelberg C. Allergy. First published: 02 March 2024
Munc13-4 regulates asthma and obesity in mice by controlling functions of CD11c+ antigen-presenting cells
Okunishi, K., Kochi, Y., Zhao, M., Wang, H., Nakagome, K. and Izumi, T. Allergy. First published: 01 March 2024
Salciccioli, I., Bhatt, P., Shalhoub, J., Marshall, D., Salciccioli, J. and Blumenthal, K. Allergy. First published: 01 March 2024
Association between gut microbiota development and allergy in infants born during pandemic-related social distancing restrictions
Korpela K, Hurley S, Ford SA, et al. Allergy. First published: 29 February 2024
Mast cell chymase suppresses functional parameters in primary human airway smooth muscle cells
Zhao, X.O., Melo, F.R., Sommerhoff, C.P., Paivandy, A. and Pejler, G. Allergy. First published: 26 February 2024
Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis
Wang N, Song J, Sun S-R, et al. Allergy. First published: 25 February 2024
Impact of air pollutants and meteorological factors on allergic rhinitis outpatient visits in Shanghai, China
Na, S., Yanan, H., Lufang, T., et al. Allergy. First published: 25 February 2024
Correspondence to “intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL-6-mediated protection associated with cecal microbiota changes”
Chen, X. and He, Y.-q. Allergy. First published: 25 February 2024
Insights in intestinal immune tolerance: The role of the cleavage form of gasdermin D
Rossi, F., Votto, M. and Castagnoli, R. Allergy. First published: 25 February 2024
Mouse eosinophil-associated ribonuclease-2 exacerbates the allergic response
Nguyen, L.M., Kanda, A., Kamioka, Y., et al. Allergy. First published: 23 February 2024
Systematic review of the association between short chain fatty acids and allergic diseases
Sasaki M, Suaini NHA, Afghani J, et al. Allergy. First published: 23 February 2024
Epidermal barrier impairment predisposes for excessive growth of the allergy-associated yeast >Malassezia on murine skin
Ruchti F, Zwicky P, Becher B, Dubrac S, LeibundGut-Landmann S. Allergy. First published: 22 February 2024
The first plant allergen to be cloned—the story of the major birch pollen allergen Bet v 1
Breiteneder, H. Allergy. First published: 21 February 2024
Reply to Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—factor analysis”
Okada, N., Oguma, T. and Asano, K. Allergy. First published: 21 February 2024
Identification of fructose-bisphosphate aldolase as new pollen allergens
Song, L.-B., Zhang, L., Zhu, Y., et al. Allergy. First published: 20 February 2024
Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities
Del Duca E, Dahabreh D, Kim M, et al. Allergy. First published: 20 February 2024
Artemisia annua sublingual immunotherapy in children with seasonal allergic rhinitis
Tang, L., Wang, P., Yang, X., et al. Allergy. First published: 20 February 2024
Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma
Devilliers, M.A., Brisebarre, A., Petit, et al. Allergy. First published: 19 February 2024
Updated epithelial barrier dysfunction in chronic rhinosinusitis: Targeting pathophysiology and treatment response of tight junctions
Huang Z-Q, Liu J, Sun L-Y, et al. Allergy. First published: 19 February 2024
Global associations of macronutrient supply and asthma disease burden
Ni, D., Senior, A.M., Raubenheimer, D., Simpson, S.J., Macia, L. and Nanan, R. Allergy. First published: 19 February 2024
A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy
Mortz CG, Parke L, Rasmussen HM, et al. Allergy. First published: 17 February 2024
The impact of indoor pollution on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma
Agache I, Canelo-Aybar C, Annesi-Maesano I, et al. Allergy. First published: 17 February 2024
Pre-existing inflammation reduces the response to contact allergens in Tmem79-deficient mice
Jee, M.H., Funch, A.B., Weber, J.F., et al. Allergy. First published: 17 February 2024
Drug hypersensitivity: Past, present and future
Torres, M.J. and Doña, I. Allergy. First published: 16 February 2024
Colostrum is required for the postnatal ontogeny of small intestine innate lymphoid type 2 cells and successful anti-helminth defences
Rekima, A., van den Elsen, L., Isnard, C., et al. Allergy. First published: 13 February 2024
Is there a direct link between skin barrier dysfunction and asthma?
Santos, A.F. Allergy. First published: 13 February 2024
Interplay of a well-known medication and newly discovered transporters driving bacteria-induced inflammation in psoriasis
Lücke, G. Allergy. First published: 13 February 2024
Response to correspondence: Prediction of adult asthma risk in early childhood using novel adult asthma predictive risk scores
Farhan, A.J., Kothalawala, D.M., Kurukulaaratchy, R.J., et al. Allergy. First published: 08 February 2024
Correspondence to “Oral immunotherapy in alpha-gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?”
Chen, Y.-C., Lin, Y.-H., Lu, C.-T., Yii, C.-Y., Chen, P.-C. and Yong, S.-B. Allergy. First published: 13 February 2024
Identification of allergens from Aspergillus fumigatus—Potential association with lung damage in asthma
Rick E-M, Woolnough K, Richardson M, et al. Allergy. First published: 09 February 2024
Transitional care of adolescents and young adults with asthma and allergy—The healthcare professional perspective
Ödling, M., Lagercrantz, B., Goksör, E., et al. Allergy. First published: 09 February 2024
Immunotherapeutic effects of specific and nonspecific mRNA-lipid nanoparticles in a mouse model of HDM-induced airway inflammation
Thanasarnthungcharoen, C., Chanasit, S., Fievez, L., et al. Allergy. First published: 08 February 2024
Heterogeneity of sensitization profiles and clinical phenotypes among patients with seasonal allergic rhinitis in Southern European countries—The @IT.2020 multicenter study
Dramburg S, Grittner U, Potapova E, et al. Allergy. First published: 05 February 2024
Dupilumab-associated ocular surface disease is characterized by a shift from Th2/Th17 toward Th1/Th17 inflammation
Thormann K, Lüthi A-S, Deniau F, et al. Allergy. First published: 05 February 2024
The impact of outdoor pollution and extreme temperatures on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma
Agache I, Canelo-Aybar C, Annesi-Maesano I, et al. Allergy. First published: 04 February 2024
Nature's pharmacy at risk: Unveiling the hidden molecular secrets of phytotherapy in the age of globalization
Traidl-Hoffmann, C. Allergy. First published: 03 February 2024
The skin microbiome in pediatric atopic dermatitis and food allergy
Tham EH, Chia M, Riggioni C, Nagarajan N, Common JEA, Kong HH. Allergy. First published: 03 February 2024
T-cell immune profile in blood of systemic mastocytosis: Association with disease features
Pérez-Pons A, Teodosio C, Jara-Acevedo M, et al. Allergy. First published: 01 February 2024
Citations: 342
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766
Citations: 147
EAACI guidelines: Anaphylaxis (2021 update)
Muraro A, Worm M, Alviani C, et al. Allergy. 2022; 77: 357–377
Citations: 118
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
Maurer M, Magerl M, Betschel S, et al. Allergy. 2022; 77: 1961–1990
Citations: 118
The role of peripheral blood eosinophil counts in COVID-19 patients
Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482
Citations: 114
Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease
Celebi Sozener Z, Ozdel Ozturk B, Cerci P, et al. Allergy. 2022; 77: 1418–1449
Citations: 105
Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice
Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432
Citations: 92
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation
Klimek, L., Novak, N., Cabanillas, B., et al. Allergy. 2021; 76: 3307-3313
Citations: 90
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639
Citations: 88/h5>
The role of allergen-specific IgE, IgG and IgA in allergic disease
Shamji MH, Valenta R, Jardetzky T, et al. Allergy. 2021; 76: 3627–3641
Citations: 82
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676
Citations: 81
Advances and highlights in allergic rhinitis
Zhang Y, Lan F, Zhang L. Allergy. 2021; 76: 3383–3389
Citations: 79
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618
Citations: 76
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353
Citations: 74
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Citations: 73
Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches
Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC. Allergy. 2022; 77: 812–826
Citations: 70
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., et al. Allergy. 2021; 76: 1640-1660
Citations: 69
Advances and highlights in biomarkers of allergic diseases
Ogulur I, Pat Y, Ardicli O, et al. Allergy. 2021; 76: 3659–3686
Citations: 69
Regulatory B cells, A to Z
Jansen, K., Cevhertas, L., Ma, S., Satitsuksanoa, P., Akdis, M. and van de Veen, W.
Citations: 62
Advances and highlights in asthma in 2021
Agache I, Eguiluz-Gracia I, Cojanu C, et al. Allergy. 2021; 76: 3390–3407
Citations: 62
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Citations: 61
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Dahlin, J.S., Maurer, M., Metcalfe, D.D., Pejler, G., Sagi-Eisenberg, R. and Nilsson, G. Allergy. 2022; 2022; 77: 83-99
February 2023 - Food Allergy and Allergic/Inflammatory Gastrointestinal Diseases
Volume 78 | Issue 2
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, et al. Allergy. 2022; 77: 734– 766
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Advances and recent developments in asthma in 2020
Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
18th World Immune Regulation Meeting
As ever, immune regulation is the hottest issue in basic and clinical sciences. With an outstanding list of speakers in this field, WIRM will be one of the key scientific event of the year 2024, being big enough to learn from other disciplines and small enough to personally meet the experts. Check out the website for more information by clicking here.
Junior Members Corner
Dear Junior Members,
The International Severe Asthma forum (ISAF) was held in a hybrid format from 5-7 October 2023 in the beautiful city of Rome (Italy). The meeting was a great success, with senior experts and juniors learning together about the most relevant scientific advances in the field of asthma research, which can be translated into clinical practice. The organising committee, which the participation of the secretary of the Junior Member Assembly (JMA), Mattia Giovannini, carefully designed a comprehensive scientific programme divided into different plenary, symposium and keynote sessions, useful practical courses, and different poster sessions, where the most exciting data were presented, and vibrant discussions took place.
Moreover, the Pediatric Allergy and Asthma Meeting (PAAM) 2023 was held in Porto, Portugal, from 2 to 4 November 2023. Junior Members (JMs) from different countries were able to attend sessions that highlight the latest scientific information regarding drug allergy in children, chronic urticaria in childhood, the management of immunodeficiencies, when the hydrolysed formula is recommended, mastocytosis and how to prevent food allergy among others. This event has also facilitated in person networking with the experts. Besides, JMs have coordinated the Clinical Village, divided into different stations depending on the topic. The latest algorithms were posted, and attendees were able to interact with JM and discuss hot topics.
Best wishes,
The Junior Member Assembly
EAACI Patients Organisation Committee Corner
The POC Reunion in the Annual Congress 2023
The POC has been participating in the EAACI Annual Congresses and focused meetings such as FAAM and PAAM since 2011. When Covid-19 pandemic and strict public health measures started in 2020, POC members continued attending the EAACI events virtually. For the first time in a long while, the POC returned to in-person participation in the Annual Congress Hamburg 2023.
Fifteen members of the committee attended the Annual Congress 2023 in-person. The special session ESS1 which was completely organised by the POC took place on the first day of the Congress with great success. Session was designed to discuss the “Benefits of engaging with patients in clinical trials and decision-making” with different stakeholders.
Giulia Gabrielli from European Medicine Agency (EMA) shared the framework for engagement between the Agency and the patients. Dr Kirsten Perrett, Director of Australia National Allergy Centre of Excellence, shared their experience in receiving the federal funding for allergy prevention and management in collaboration with the POC member Allergy & Anaphylaxis Australia. Susanna Palkonen, Director of European Federation of Allergy and Airways Diseases Patients Associations (EFA) presented their long-lasting track record in participation to research projects. POC Member Mikaela Odemyr, President of Asthma and Allergy Association Sweden shared her experience as a patient representative in participating the research design and planning process.
The session chairs were Carla Jones, CEO of Allergy UK, past POC Co-Chair and Ozlem Ceylan, President of Living with Allergy Association, current POC Chair. The session also had a panel discussion where chairs invited the audience to share their experiences and best practises.
Additionally, POC members Sabine Schnadt (DAAB-Germany) presented “Managing the risk of patients with peanut allergy: the value of thresholds of reaction” in the industry session, Patricia Carmelo and Carolina Olivares (Fundacion Creciendo con Alergias Alimenarias-Chile) had two poster presentations; “Food Allergens that trigger anaphylaxis in children in Chile” and “Adrenaline Auto-injector in Chile, National Survey 2020”.
Several POC members attended the Beat Allergy Run & Walk on the 10th of June. The event was organised to contribute on providing much-needed aid as the collected funds were sent to those affected by the earthquakes in Turkey.
The POC believes the conferences and in-person meetings are useful in staying up to date with new developments in medicine, dissemination of knowledge, enabling interaction with opinion leaders, networking, developing consensus, and adoption of newer ideas relevant to the patient community. Going forward, committee members consider hybrid conventions a decent opportunity to increase accessibility and inclusivity. In 2024, POC is planning to attend the Annual Congress in Valencia and FAAM in Athens.